AAAAAA
Results:
1-12
|
Results: 12
Authors:
Goren, D
Horowitz, AT
Tzemach, D
Tarshish, M
Zalipsky, S
Gabizon, A
Citation: D. Goren et al., Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump, CLIN CANC R, 6(5), 2000, pp. 1949-1957
Authors:
Hubert, A
Lyass, O
Pode, D
Gabizon, A
Citation: A. Hubert et al., Doxil (Caelyx): an exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancer, ANTI-CANC D, 11(2), 2000, pp. 123-127
Authors:
Safra, T
Muggia, F
Jeffers, S
Tsao-Wei, DD
Groshen, S
Lyass, O
Henderson, R
Berry, G
Gabizon, A
Citation: T. Safra et al., Pegylated liposomal doxorubicin (doxil): Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m(2), ANN ONCOL, 11(8), 2000, pp. 1029-1033
Authors:
Lyass, O
Uziely, B
Ben-Yosef, R
Tzemach, D
Heshing, NI
Lotem, M
Brufman, G
Gabizon, A
Citation: O. Lyass et al., Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma, CANCER, 89(5), 2000, pp. 1037-1047
Authors:
Lotem, M
Hubert, A
Lyass, O
Goldenhersh, MA
Ingber, A
Peretz, T
Gabizon, A
Citation: M. Lotem et al., Skin toxic effects of polyethylene glycol-coated liposomal doxorubicin, ARCH DERMAT, 136(12), 2000, pp. 1475-1480
Authors:
Cabanes, A
Even-Chen, S
Zimberoff, J
Barenholz, Y
Kedar, E
Gabizon, A
Citation: A. Cabanes et al., Enhancement of antitumor activity of polyethylene glycol-coated liposomal doxorubicin with soluble and liposomal interleukin 2, CLIN CANC R, 5(3), 1999, pp. 687-693
Authors:
Gabizon, A
Horowitz, AT
Goren, D
Tzemach, D
Mandelbaum-Shavit, F
Qazen, MM
Zalipsky, S
Citation: A. Gabizon et al., Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: In vitro studies, BIOCONJ CHE, 10(2), 1999, pp. 289-298
Authors:
Bandak, S
Goren, D
Horowitz, A
Tzemach, D
Gabizon, A
Citation: S. Bandak et al., Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models, ANTI-CANC D, 10(10), 1999, pp. 911-920
Authors:
Nir, S
Barenholz, Y
Gabizon, A
Citation: S. Nir et al., Untitled, J LIPOS RES, 9(1), 1999, pp. 162-166
Authors:
Bandak, S
Ramu, A
Barenholz, Y
Gabizon, A
Citation: S. Bandak et al., Reduced UV-induced degradation of doxorubicin encapsulated in polyethyleneglycol-coated liposomes, PHARM RES, 16(6), 1999, pp. 841-846
Authors:
Symon, Z
Peyser, A
Tzemach, D
Lyass, O
Sucher, E
Shezen, E
Gabizon, A
Citation: Z. Symon et al., Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes, CANCER, 86(1), 1999, pp. 72-78
Authors:
Goren, D
Gabizon, A
Citation: D. Goren et A. Gabizon, Pharmacologic advantages of anthracyclines encapsulated in poly-ethylene-glycol coated Stealth liposomes: Potential for tumor targeting, MEDICAL APPLICATIONS OF LIPOSOMES, 1998, pp. 259-274
Risultati:
1-12
|